Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device -- Ignore unavailable to you. Want to Upgrade?

To: MaximilianII who wrote (113)	3/20/1998 11:21:00 AM
From: (no name provided)	Respond to of 246

>1. Don't see the relevance to AMA's reluctance to accept unrefined and developed technology in the 1980's. Not only did the AMA reject thermography in the early 80s, but so did HCFA and withdrew reimbursement in 1984. The Office of Health Technology Assessment in 1983 stated that thermography needed further development. BreastAlert has not been changed since approval in 1983. > 2. This will be reported in time. Also, the sophistication of the BA represents a significant barrier to entry. What sophistication? There is as much sophistication in the little liquid crystal thermometers I put on my aquarium. > 3. Extensive clinical trials. All done in the early 80s. Are we to assume that other breast cancer diagnostic modalities have not improved in 15+ years. The so-called extensive trials showed that the BreastAlert was less sensitive than mammography in the early 80s with more false positives. >4. Patent runs out and HMSC is way ahead of any potential competition. >5. This is an adjunctive screening device and does not requires the same approval as Type 1 Devices. They already have approval to sell Type 2 medical device. Doesn't that tell you something. Nobody wants this patent. No one would buy this technology. They could have it for free in two years. In the meantime, even if a large company were stupid enough to develop such a device, they could develop it without infringing the patent and market as soon as the patent expires. Kafka666